CRISPR–Cas9 has revolutionized biomedical research. Studies in the past few years have achieved notable successes in hepatology, such as correction of genetic disease genes and generation of liver cancer animal models. Where does this technology stand at the frontier of basic and translational liver research?
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172947 | PMC |
http://dx.doi.org/10.1038/nrgastro.2018.11 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!